0001062993-21-002790.txt : 20210317 0001062993-21-002790.hdr.sgml : 20210317 20210317165318 ACCESSION NUMBER: 0001062993-21-002790 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McAvoy David R. CENTRAL INDEX KEY: 0001758842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 21751203 MAIL ADDRESS: STREET 1: C/O ENDOCYTE, INC., 3000 KENT AVENUE STREET 2: SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brickell Biotech, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-03-16 0000819050 Brickell Biotech, Inc. BBI 0001758842 McAvoy David R. C/O BRICKELL BIOTECH, INC. 5777 CENTRAL AVENUE, SUITE 102 BOULDER CO 80301 0 1 0 0 General Counsel and CCO Common Stock 2021-03-16 4 M 0 25000 A 100883 D Common Stock 2021-03-16 4 F 0 8750 1.14 D 92133 D Common Stock 6000 I By spouse Restricted Stock Units 2021-03-16 4 M 0 25000 0 D Common Stock 25000 0 D Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. These RSUs vested in full on March 16, 2021. /s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed) 2021-03-17